KETOROLAC TROMETHAMINE INJECTION USP
JAMP PHARMA CORPORATION
Quick answers
Is there a shortage of KETOROLAC TROMETHAMINE INJECTION USP in Canada?
No. There is no current shortage of KETOROLAC TROMETHAMINE INJECTION USP 30MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
ACULAR
ABBVIE CORPORATION
TORADOL IM
ATNAHS PHARMA UK LIMITED
TORADOL
AA PHARMA INC
APO-KETOROLAC
APOTEX INC
MINT-KETOROLAC
MINT PHARMACEUTICALS INC
MAR-KETOROLAC
MARCAN PHARMACEUTICALS INC
DIN
02523310
Strength
30MG
Dosage Form
Solution
Route
Intramuscular
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from JAMP PHARMA CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
225MG · DIN 02420694
250MG · DIN 02529459
50MG · DIN 02423227
5MG · DIN 02429217
10MG · DIN 02429225
2.5MG · DIN 02492199
DIN 02532174
DIN 02532182
500MG · DIN 02523825
2MG · DIN 02553341
100MG · DIN 02509172
25MG · DIN 02509164